PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: AnaSpec, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

AnaSpec Introduces New Line of Reagents and Kits for Study of Protein Phosphorylation - AnaSpec, a leading provider of integrated proteomics solution, has released a new line of reagents and kits for the study of protein phosphorylation.
AnaSpec Introduces New Line of Reagents and Kits for Study of Protein Phosphorylation

 

NewswireToday - /newswire/ - San Jose, CA, United States, 2006/06/06 - AnaSpec, a leading provider of integrated proteomics solution, has released a new line of reagents and kits for the study of protein phosphorylation..

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Cellular phosphorylation is a reversible, covalent modification of a protein or lipid that serves to modify the activity of the phosphorylated molecule by inducing conformational changes within the molecule. This modification occurs either through the addition of phosphate groups via the transfer of the terminal phosphate from a phosphate donor, e.g. ATP to an amino acid residue (regulated by kinases) and/or by their removal (regulated by phosphatases). The functions of these post-translational modifications include the alteration of the activity of a substrate, its subcellular localization, binding properties or association with other proteins. Dedicated to providing researchers with a broad spectrum of world-class research tools, AnaSpec is pleased to present one of the world’s most comprehensive collections of peptides and related reagents to assist you in investigating the functions of protein kinases and phosphatases in biological systems.

Phosphorylation-Related Peptides – Utilizing optimized Fmoc methodologies and orthogonal protection strategy for multiple phosphorylated peptides, AnaSpec’s chemists routinely synthesize mono-, di-, tri- or multiple phosphoamino acids sequences at our facilities in San Jose, CA.

Over 280 protein phosphorylation-related peptides, including substrates for Calcium/Calmodulin-dependent protein kinases; cAMP related kinases; Cyclin-dependent kinase 5 (CDK5); Kemptide; MAPK (including EGFR) and PKC, Protein Tyrosine Kinase (PTK) and more. These substrates include both phosphorylated and non-phosphorylated; fluorophore (green or red) or biotin-labeled kinase; and, phosphatase substrates.

Phosphopeptide Mass Standards - Contains 6 individually-packed phosphopeptides at 1 ug each. These phosphopeptides can be used for the characterization of affinity purified phosphorylated peptides in liquid chromatography / mass spectrometry.

EnzoLyte™ Serine/Threonine or Tyrosine Protein Kinase Substrate Sampler Kits - FAM-, TAMRA-, or Biotin-Labeled. Designed to facilitate the characterization of an appropriate peptide substrate for developing a particular Ser/Thr kinase or Tyr protein kinase assay, each kit contains a series of FAM, TAMRA, and/or Biotin-labeled protein kinase substrates.

EnzoLyte™ Phosphatase Assay Kits - In addition to colorimetric pNPP-based assay kits, AnaSpec also provides a series of FDP and MFP-based fluorimetric assay kits for enhanced measurement of phosphatase activity. These fluorimetric assays are 50-100X more sensitive than pNPP; have a wider dynamic range; and can be monitored using the popular green fluorescence filter (Ex/Em=490/520 nm). So whether your research calls for measuring (secreted or non-secreted) alkaline phosphatase, protein phosphatase, or acid phosphatase activity, the EnzoLyte™ Phosphatase Assay Kits are the phosphatase assay kits of choice.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: AnaSpec, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


AnaSpec Introduces New Line of Reagents and Kits for Study of Protein Phosphorylation

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Albert Olson Hong 
408-452-5055 info[.]anaspec.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AnaSpec, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From AnaSpec, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Explorers Vacation Club

Visit MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)